How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

IS

NASDAQ:ISEE
Get a brief AI stock analysisSaves ~ 15 minutes of your time

IS

IVERIC bio IncNASDAQ ISEE Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is ISEE undervalued compared to its fair value?

The fair value of ISEE stock is hidden USD. Relative to the market price of 0 USD IVERIC bio Inc is hidden.

IVERIC bio, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Its lead asset is its clinical-stage product candidate...[More about valuation]

IVERIC bio Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

5.512 $B

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.527

FINANCIALS

IVERIC bio financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.074 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.072 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.61 B
0.48 B

Financial Position Analysis

Assets

0.61 B
Current Assets
0.61 B
Total non-current assets
0.0019 B

Total current liabilities
0.039 B
Total non-current liabilities
0.097 B

Cash Flow Statement

-0.051 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.051 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

IVERIC bio fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is ISEE attractive for investment based on fundamental analysis?

ISEE stock rating is hidden. IVERIC bio is a hidden by Eyestock methodology.

Get ISEE Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

ISEE analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for ISEE to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

IVERIC bio Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

IVERIC bio Inc dividends

ISEE dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About ISEE stock

About the company IVERIC bio Inc

Market cap $B

5.512

Dividend yield

Shares outstanding

137.122 B

IVERIC bio, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Its lead asset is its clinical-stage product candidate, avacincaptad pegol, which is also referred to as ACP or Zimura, a complement C5 inhibitor. Zimura is targeting diseases including geographic atrophy (GA), intermediate age-related macular degeneration (AMD), and autosomal recessive Stargardt disease (STGD1). In addition to ACP, the Company is also developing its preclinical product candidate, IC-500, a high temperature requirement A serine peptidase 1 protein (HtrA1) inhibitor for GA secondary to AMD and potentially other age-related retinal diseases. Its portfolio also includes several ongoing gene therapy research programs, each of which uses adeno-associated virus (AAV) for gene delivery. These AAV mediated gene therapy programs are targeting the orphan inherited retinal diseases (IRDs).

ISEE profile

  • Ticker

    ISEE

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    25 September 2013

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    74

  • City

    Parsippany

  • Address

    8 Sylvan Way, Suite 2372

  • Cusip

    46583P102